State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus
Objective Patients with lupus erythematosus (LE) are at heightened risk for clinical events, chiefly heart attacks and strokes, from atherosclerotic cardiovascular disease (ASCVD). We recently proposed new guidelines to assess and manage ASCVD event risk specifically in LE. Here, we examined current...
Main Authors: | Victoria P Werth, Kevin Jon Williams, Rui Feng, Megan Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-08-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/10/2/e000908.full |
Similar Items
-
Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis
by: Emily Keyes, BA, et al.
Published: (2021-12-01) -
Emerging Therapies in Cutaneous Lupus Erythematosus
by: Grant Sprow, et al.
Published: (2022-07-01) -
Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis
by: Julianne Kleitsch, BA, et al.
Published: (2023-11-01) -
P11.11 SYSTEMIC LUPUS ERYTHEMATOSUS AND CARDIOVASCULAR EVENTS
by: A. Cypiene, et al.
Published: (2011-11-01) -
Comparing dermatologic patient-reported outcome measures in cutaneous lupus erythematosus
by: Victoria P Werth, et al.
Published: (2022-09-01)